Novo Nordisk
NVO
#15
Rank
S$777.86 B
Marketcap
$175.49
Share price
2.02%
Change (1 day)
37.82%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of June 2024 : S$10.69 B

According to Novo Nordisk's latest financial reports the company's total debt is S$10.69 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$5.28 B6.12%
2022-12-31S$4.97 B-9.01%
2021-12-31S$5.47 B141.74%
2020-12-31S$2.26 B150.39%
2019-12-31S$0.90 B740.89%
2018-12-31S$0.10 B-70.57%
2017-12-31S$0.36 B678.36%
2016-12-31S$46.92 M-78.92%
2015-12-31S$0.22 B43.28%
2014-12-31S$0.15 B208.03%
2013-12-31S$50.44 M-53.51%
2012-12-31S$0.10 B-43.62%
2011-12-31S$0.19 B-62.38%
2010-12-31S$0.51 B36.13%
2009-12-31S$0.37 B-40.06%
2008-12-31S$0.62 B62.25%
2007-12-31S$0.38 B-6.16%
2006-12-31S$0.41 B-41.98%
2005-12-31S$0.70 B54.9%
2004-12-31S$0.45 B-8.13%
2003-12-31S$0.49 B39.51%
2002-12-31S$0.35 B-22.95%
2001-12-31S$0.46 B2.14%
2000-12-31S$0.45 B-8.32%
1999-12-31S$0.49 B-26.73%
1998-12-31S$0.67 B-12.97%
1997-12-31S$0.77 B62.71%
1996-12-31S$0.47 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
S$89.45 B 736.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$37.63 B 251.75%๐Ÿ‡บ๐Ÿ‡ธ USA
S$70.34 B 557.48%๐Ÿ‡บ๐Ÿ‡ธ USA
S$33.16 B 209.97%๐Ÿ‡ซ๐Ÿ‡ท France